Menu
Back to User profile » Dr Maurizio Benucci
Papers published by Dr Maurizio Benucci:
Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F
ClinicoEconomics and Outcomes Research 2019, 11:405-409
Published Date: 7 June 2019
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Li Gobbi F, Cassarà E, Kaloudi O, Cantini F
Therapeutics and Clinical Risk Management 2018, 14:2097-2111
Published Date: 24 October 2018
Focus on biosimilar etanercept – bioequivalence and interchangeability
Cantini F, Benucci M
Biologics: Targets and Therapy 2018, 12:87-95
Published Date: 30 August 2018
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
Benucci M, Bandinelli F, Damiani A, Li Gobbi F, Infantino M, Grossi V, Manfredi M
Journal of Inflammation Research 2018, 11:247-252
Published Date: 7 June 2018
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F
Biologics: Targets and Therapy 2018, 12:37-41
Published Date: 31 January 2018
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
Benucci M, Ravasio R, Damiani A
ClinicoEconomics and Outcomes Research 2017, 9:403-410
Published Date: 14 July 2017
Costs associated with rheumatoid arthritis in Italy: past, present, and future
Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A
ClinicoEconomics and Outcomes Research 2016, 8:33-41
Published Date: 10 February 2016
Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
Sangiorgi D, Benucci M, Nappi C, Perrone V, Buda S, Degli Esposti L
Biologics: Targets and Therapy 2015, 9:119-127
Published Date: 6 November 2015
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
Benucci M, Li Gobbi F , Meacci F, Manfredi M, Infantino M, Severino M, Testi S, Sarzi-Puttini P, Ricci C, Atzeni F
Biologics: Targets and Therapy 2015, 9:7-12
Published Date: 17 February 2015
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F
Biologics: Targets and Therapy 2013, 7:69-75
Published Date: 15 March 2013